Pay in 4 interest-free payments of $5.22 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
These studies have used radiolabeled or bioassay-tracked peptide to demonstrate that BPC-157 reaches target tissues after parenteral injection in rodents
Cenexa Labs has no affiliation with Professor Ng or Monash University, and this information does not constitute an endorsement of any products or services
Benefits of AOD-9604 1
Important Safety Reminders Medical Supervision Required: AOD-9604 should only be used under qualified medical supervision Baseline and monitoring laboratory testing is recommended Individual contraindications and health status must be evaluated AOD-9604 is not FDA-approved for any indication Contraindications and Precautions: Pregnancy and breastfeeding (no safety data available) Active malignancy (discuss with oncologist) Pediatric use (not studied in children) Significant organ dysfunction (limited safety data) Report Concerns: Any unexpected symptoms or adverse effects should be reported to your healthcare provider promptly
US$ 20.91
US$ 24.77
,aspect=ignore)
US$ 22.00
US$ 27.33
